Hydroxy Ziprasidone | CAS 884305-08-2 - Request Quote
Hydroxy Ziprasidone
| SZ CAT No: | SZ-Z002013 |
| CAS No | 884305-08-2 |
| Mol.F. | C21H21ClN4O2S |
| Mol.Wt. | 428.9 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Hydroxy Ziprasidone is chemically 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)-1-hydroxyethyl)-6-chloroindolin-2-one. Hydroxy Ziprasidone is supplied with detailed characterization data compliant with regulatory guideline. Hydroxy Ziprasidone can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pharmaceutical Reference Standards.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 884305-08-2
Purchase 884305-08-2
Order 884305-08-2
Enquire 884305-08-2
price of 884305-08-2
884305-08-2 Supplier
884305-08-2 Manufacturer
884305-08-2 Exporter
buy high quality Hydroxy Ziprasidone
Purchase Hydroxy Ziprasidone
Hydroxy Ziprasidone suppliers
Hydroxy Ziprasidone manufacturers
Hydroxy Ziprasidone price
Order Hydroxy Ziprasidone
Enquire Hydroxy Ziprasidone
Hydroxy Ziprasidone cost
Hydroxy Ziprasidone Supplier
Hydroxy Ziprasidone Distributor
Hydroxy Ziprasidone for Method Validation
Pharmaceutical Reference Standards Reference Standard
Hydroxy Ziprasidone for ANDA Filing
Hydroxy Ziprasidone for Forced Degradation Studies
Hydroxy Ziprasidone Identification Standards
Hydroxy Ziprasidone for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


